Medical News Today: Colorectal Cancer News
Colorectal cancer, also called colon cancer, rectal cancer or bowel cancer almost always occurs in the large bowel - cancer of the small bowel is rare. Symptoms of colorectal cancer include blood in your stools, a change in normal bowel habits, a lump that your doctor can feel in your back passage, weight loss, pain in the abdomen or back passage, and anemia. Treatment depends on where the cancer is in the bowel and how far it has spread but may include surgery, chemotherapy and radiation.
Updated: 9 hours 6 min ago
Danish researchers from Aarhus University Hospital and Aarhus University are behind a possible breakthrough in the treatment of colorectal cancer.
Some bacteria, called fusobacteria, commonly found in the mouth, use a sugar-binding protein to stick to developing colorectal polyps and cancers, according to a new study by researchers from...
Bacteria commonly found in the mouth can travel through the bloodstream and use a sugar-binding protein to stick to and worsen colorectal tumors.
Many types of cancer are caused by gene mutations in the signalling pathways that control cell growth, such as the hedgehog signalling pathway.
The formation of large numbers of polyps in the colon has a high probability of developing into colon cancer, if left untreated.
Correlation between rare mutation in bowel cancers and a better prognosis raises possibility that patients with some tumors may not need chemotherapy after surgery.
People with the disease may benefit from boosting dietary oily fish content, say researchers.
Findings open up 'precision medicine' approach to prevention, diagnosis and treatment.
Gut microbes likely influence colon cancer susceptibility, says study that implanted embryos of cancer-prone rats into mothers with varying gut microbiota.
Researchers have tissue-engineered a model of the human colon for tracking the genetic changes that drive cancer from abnormal mass to invasive tumor.
New analysis shows patients with metastatic colorectal cancer treated with radiation therapy show better response than those receiving chemotherapy alone.
Researchers at Osaka University, clarified that T-lymphocytes expressing FOXP3 at a low level found in colorectal cancers (CRCs) facilitated cancer immunity.
Researchers have identified genetic mutations affecting the immune system which may lead to the development of more than one bowel tumour at the same time.
XBiotech Inc., developer of next-generation True Human™ antibody therapies, has presented positive results from a pivotal Phase III trial of Xilonix™, the company's lead monoclonal...
Anti-PD-L1 immunotherapy shows response in microsatellite-stable metastatic colorectal cancer in combination with MEK inhibition
Anti-PD-L1 immunotherapy may achieve a response in patients with microsatellite-stable metastatic colorectal cancer if combined with a MEK inhibitor, according to phase I data presented at the ESMO...
The Daily Meal investigate whether eating an ounce of walnuts every day lowers the risk of contracting colon cancer. Researchers from UConn Health say yes.
For the majority of patients with large or difficult to remove colorectal polyps (growths in the colon), the incidence of cancer is actually lower than previously thought, and using more advanced...
Study: Visits with primary care doctor result in more colon cancer screening and better follow-up of abnormal results
People who visit their primary care physicians are more likely to get potentially life-saving colon cancer screenings and follow up on abnormal stool blood test results - even in health systems...
Who should consider colorectal cancer (CRC) screening and why? CRC is a common and costly disease, largely of the elderly, with nearly 25% of cases diagnosed among patients aged 75-84 years, but...
A landmark study has given the most detailed picture yet of the genetics of bowel cancer - the UK's fourth most common cancer.